Indication
End Stage Renal Disease (ESRD)
1 clinical trial
1 product
Clinical trial
Novel Desensitization Protocol With Proteasome Inhibitor and Costimulation Blockade for Highly Sensitized Patients to Allow for Successful Kidney Transplantation. A Pilot Study.Status: Recruiting, Estimated PCD: 2024-09-01
Product
Belatacept